Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. HUTCHMED (China) Limited
  6. News
  7. Summary
    HCM   KYG4672N1198

HUTCHMED (CHINA) LIMITED

(HCM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

HUTCHMED China : Launches Hong Kong IPO

06/18/2021 | 02:51am EDT


ę MT Newswires 2021
All news about HUTCHMED (CHINA) LIMITED
08/03HUTCHMED CHINA : Jefferies Initiates Hutchison China MediTech at Buy Rating With..
MT
07/28HUTCHMED CHINA : H1 Net Loss Widens Even as Revenue Jumps
MT
07/28HUTCHMED CHINA : Swings to Wider 1H Loss, Revenue Rises; Reaffirms 2021 Targets
MT
07/28HUTCHMED CHINA : Reports 2021 Interim Results and Provides Business Updates (For..
PU
07/28HUTCHMED CHINA : Reports 2021 Interim Results and Provides Business Updates
PU
07/28HUTCHMED CHINA : Reports 2021 Interim Results and Provides BusinessáUpdates
AQ
07/28HUTCHMED Limited Provides Revenue Guidance for the Year 2021
CI
07/28Hutchmed China Limited Reports Earnings Results for the Half Year Ended June ..
CI
07/28HUTCHMED CHINA : — Follows multiple Phase II studies of ORPATHYS« in Asia ..
PU
07/28HUTCHMED CHINA : AstraZeneca Begin Mid-Stage Trial For Gastric Cancer Drug
MT
More news
Financials (USD)
Sales 2021 343 M - -
Net income 2021 -268 M - -
Net cash 2021 716 M - -
P/E ratio 2021 -22,3x
Yield 2021 -
Capitalization 7 169 M 7 176 M -
EV / Sales 2021 18,8x
EV / Sales 2022 15,1x
Nbr of Employees 1 280
Free-Float 51,3%
Chart HUTCHMED (CHINA) LIMITED
Duration : Period :
HUTCHMED (China) Limited Technical Analysis Chart | HCM | KYG4672N1198 | MarketScreener
Technical analysis trends HUTCHMED (CHINA) LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 5
Last Close Price 8,37 $
Average target price 9,59 $
Spread / Average Target 14,5%
EPS Revisions
Managers and Directors
Christian Hogg Chief Executive Officer & Executive Director
Chig Fung Cheng Chief Financial Officer & Executive Director
Chi Keung To Executive Chairman
Wei Guo Su Executive Director & Chief Scientific Officer
Marek Kania Chief Medical Officer & Managing Director
Sector and Competitors
1st jan.Capi. (M$)
HUTCHMED (CHINA) LIMITED31.09%7 176
JOHNSON & JOHNSON10.15%456 367
ROCHE HOLDING AG14.56%340 460
PFIZER, INC.22.77%252 960
ELI LILLY AND COMPANY55.45%237 950
NOVARTIS AG-0.36%223 613